Year after year, The Ronald Reagan UCLA Medical Center is ranked number one in the West by U.S. News and World Report's annual survey of "America's Best Hospitals."
The Ronald Reagan UCLA Medical Center stands as the dominant building on the south campus of UCLA. Created by renowned architect I. M. Pei, the building conveys the inspiration and promise of healing and scientific discovery. The 1,050,000-square-foot hospital houses 520 beds in private rooms and features a dedicated interventional floor with 23 operating rooms. The 10-story (eight stories above ground) structure combines the operations of Ronald Reagan UCLA Medical Center, Stewart and Lynda Resnick Neuropsychiatric Hospital at UCLA, and UCLA Mattel Children's Hospital.
The new surgical suites incorporate state-of-art facilities including ergonomically position flat-screen monitors placed on articulating arms that can be brought into the surgical filed and cameras built into the handle of the operating room lights that enable images to be displayed on a wall mounted plasma screen. Two-way video-conferencing capabilities make it possible for full-motion , high-quality images and audio to be transmitted within or outside the hospital for both teaching and consultation during surgeries.
The fellow works with a team of residents and is responsible for the day-to-day activities of the service and actively participates in the gynecologic oncology OR cases as either primary surgeon or co-surgeon. Surgical cases are performed open, laparoscopically and robotically as appropriate. The fellows attends medical oncology and radiation oncology clinics and receives training in radiation treatment planning from radiation physicists. Fellows participate in brachytherapy cases with the radiation oncology faculty. The fellow is also in charge of the weekly multidisciplinary patient care conference.
Fellows rotating at UCLA work with four gynecologic oncology attendings.
Dr. Robin Farias-Eisner, MD, PhD is a gynecologic oncology attending that supervises and trains the clinical fellows rotating at UCLA. Dr. Farias-Eisner is the Division Director of Gynecologic Oncology and Professor in the Department of Obstetrics and Gynecology. He received a PhD degree in Molecular Biology at UCLA and has an independent laboratory investigating novel targeted therapists for gynecologic malignancies, molecular mechanisms of gynecologic tumorigenesis and cell signaling and the early detection of gynecologic malignancies. Dr. Farias-Eisner mentors fellows in basic and translational science research projects.
Dr. Sanaz Memarzadeh, MD, PhD is a gynecologic oncology attending that supervises and trains the clinical fellows rotating at UCLA. She is an Associate Professor and Director of the G.O. Discovery Laboratory. Dr. Memarzadeh received a PhD in Molecular Biology at UCLA. Her independent laboratory studies the therapeutic targeting of serous stem cells, the mechanisms of progesterone sensitivity and resistance in endometrial cancer and targeting of self-renewal defects in endometrial progenitors as a therapy for endometriosis. Dr. Memarzadeh mentors fellows in basic and translational science research projects. Dr. Memarzadeh is the educational site-director for the UCLA clinical site.
Dr. Joshua Cohen, MD is a gynecologic oncology attending that supervises and trains the clinical fellows rotating at UCLA, and mentors fellows in clinical research projects. Dr. Cohen is a Health Sciences Assistant Clinical Professor of Obstetrics and Gynecology. Dr. Cohen completed his medical degree at Northwestern University Feinberg School of Medicine, his obstetrics & gynecology residency at UCSF School of Medicine and his obstetrics & gynecology fellowship at UCLA School of Medicine. Dr. Cohen is a board certified gynecologic oncologist and the program director for the UCLA gynecologic oncology fellowship. He has extensive experience in minimally invasive gynecologic surgical procedures including robotic surgery and sentinel lymph node dissection. Dr. Cohen is committed to providing cutting edge clinical trials for patients with a focus on personalized medicine.